Qualitek Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve I. To consider and approve the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Qualitek Labs has informed BSE that its Board of Directors will meet on Thursday, 29th May 2025. The main agenda item is to consider and approve the Audited Financial Results (Standalone & Consolidated) for the half-year and financial year ended 31st March 2025, along with the Auditor's Report. The Board will also reconsider the granting of loans, guarantees, or security to subsidiaries or other body corporates under Sections 185/186 of the Companies Act, 2013. Importantly, the Board will consider a proposal to issue equity shares of Qualitek Labs to the shareholders of Intersellar Testing Centre Private Limited as part of a share swap arrangement. The valuation reports and the swap ratio for this transaction will also be approved at the meeting. The trading window for the company's securities has been closed since 1st April 2025 and will remain closed until 48 hours after the results are declared.
This is an advance intimation, so no immediate price impact. Once the meeting concludes on 29th May, investors will get the first look at full-year FY25 audited numbers and clarity on whether Qualitek Labs is acquiring Intersellar Testing Centre through a share swap, which could dilute existing shareholders if approved.